<ѻýҕl>Tirzepatide Wins FDA Approval for Weight Lossѻýҕl> Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<ѻýҕl>Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Boomsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 08, 2023
<ѻýҕl>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplantѻýҕl> Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<ѻýҕl>Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil?ѻýҕl> News and commentary from the endocrinology world Nov 07, 2023
<ѻýҕl>Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trialѻýҕl> Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
<ѻýҕl>Gene Therapy Controls Diabetic Eye Disease for at Least a Yearѻýҕl> All but one patient with nonproliferative diabetic retinopathy had stable disease or improvement Nov 06, 2023
<ѻýҕl>Eye Drops Make Bid for Role in Diabetic Macular Edemaѻýҕl> Improved visual acuity, retinal thickness at 6 and 12 weeks, but treatment burden questioned Nov 05, 2023
<ѻýҕl>ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Diseaseѻýҕl> But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
<ѻýҕl>Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2Dѻýҕl> Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
<ѻýҕl>Year in Review: Type 2 Diabetesѻýҕl> New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<ѻýҕl>Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancerѻýҕl> News and commentary from the endocrinology world Oct 31, 2023
<ѻýҕl>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 30, 2023
<ѻýҕl>Diabetic Eye Screening: Reducing Frequency May Raise Retinal Risksѻýҕl> Switching from annual to biennial exams would delay diabetic retinopathy diagnoses, study shows Oct 27, 2023
<ѻýҕl>Another Study Highlights Metformin's Dementia Protection Propertiesѻýҕl> Association appeared irrespective of HbA1c level Oct 25, 2023
<ѻýҕl>Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids?ѻýҕl> News and commentary from the endocrinology world Oct 24, 2023
<ѻýҕl>Counterfeit Ozempic; Mary Lou Retton Discharged; No Such Thing as Free Will?ѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 24, 2023
<ѻýҕl>CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetesѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 20, 2023
<ѻýҕl>Highly Potent Statin Stands Out for Diabetes, Cataract Risksѻýҕl> Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
<ѻýҕl>Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kidsѻýҕl> These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
<ѻýҕl>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Changeѻýҕl> Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<ѻýҕl>Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Testѻýҕl> News and commentary from the endocrinology world Oct 10, 2023
<ѻýҕl>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻýҕl> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻýҕl>Inflammation of the Aorta; Afib in the Hospitalѻýҕl> Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
<ѻýҕl>CPAP Turns in Mixed Results for Patients With Diabetic Eye Diseaseѻýҕl> Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<ѻýҕl>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Riskѻýҕl> Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<ѻýҕl>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetesѻýҕl> The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<ѻýҕl>Mixed Bag for Early Metformin in Gestational Diabetesѻýҕl> EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<ѻýҕl>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻýҕl> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻýҕl>Pharmacists Improve Diabetes Control for Hispanic Patientsѻýҕl> Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
<ѻýҕl>MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraisingѻýҕl> ѻýҕl reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
<ѻýҕl>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancerѻýҕl> Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<ѻýҕl>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻýҕl> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻýҕl>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugsѻýҕl> Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
<ѻýҕl>Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuitsѻýҕl> News and commentary from the endocrinology world Sep 26, 2023
<ѻýҕl>AI System Outperforms Standard Review of Imaging for Retinal Diseaseѻýҕl> Offers potential to reduce current manual grading workload Sep 25, 2023
<ѻýҕl>The GLP-1 Agonist Plateau No One's Talking Aboutѻýҕl> Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
<ѻýҕl>FDA Approves Another SGLT2 Inhibitor for Treating CKDѻýҕl> Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
<ѻýҕl>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetesѻýҕl> We haven't seen "the best version of this device," said panel member Sep 22, 2023
<ѻýҕl>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.ѻýҕl> Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<ѻýҕl>Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical?ѻýҕl> News and commentary from the endocrinology world Sep 19, 2023